How are GH long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the GH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 59.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$920.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a GH long call?

The breakeven for the GH long call priced on this page is roughly $104.20 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GH market-implied 1-standard-deviation expected move is approximately 17.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current GH implied volatility affect this long call?

GH ATM IV is at 59.60% with IV rank near 14.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

GH Long Call Strategy

GH (Guardant Health, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

GH (Guardant Health, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $13.06B, a beta of 1.49 versus the broader market, a 52-week range of 36.36-120.74, average daily share volume of 2.1M, a public-listing history dating back to 2018, approximately 2K full-time employees. These structural characteristics shape how GH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.49 indicates GH has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on GH?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current GH snapshot

As of May 15, 2026, spot at $95.32, ATM IV 59.60%, IV rank 14.84%, expected move 17.09%. The long call on GH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long call structure on GH specifically: GH IV at 59.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a GH long call, with a market-implied 1-standard-deviation move of approximately 17.09% (roughly $16.29 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GH expiries trade a higher absolute premium for lower per-day decay. Position sizing on GH should anchor to the underlying notional of $95.32 per share and to the trader's directional view on GH stock.

GH long call setup

The GH long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GH near $95.32, the first option leg uses a $95.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GH chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GH shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$95.00	$9.20

GH long call risk and reward

Net Premium / Debit: -$920.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$920.00
Breakeven(s): $104.20
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

GH long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on GH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$920.00
$21.08	-77.9%	-$920.00
$42.16	-55.8%	-$920.00
$63.23	-33.7%	-$920.00
$84.31	-11.6%	-$920.00
$105.38	+10.6%	+$118.34
$126.46	+32.7%	+$2,225.80
$147.53	+54.8%	+$4,333.27
$168.61	+76.9%	+$6,440.74
$189.68	+99.0%	+$8,548.21

When traders use long call on GH

Long calls on GH express a bullish thesis with defined risk; traders use them ahead of GH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

GH thesis for this long call

The market-implied 1-standard-deviation range for GH extends from approximately $79.03 on the downside to $111.61 on the upside. A GH long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current GH IV rank near 14.84% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GH at 59.60%. As a Healthcare name, GH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GH-specific events.

GH long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GH alongside the broader basket even when GH-specific fundamentals are unchanged. Long-premium structures like a long call on GH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current GH chain quotes before placing a trade.

Frequently asked questions

What is a long call on GH?: A long call on GH is the long call strategy applied to GH (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With GH stock trading near $95.32, the strikes shown on this page are snapped to the nearest listed GH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are GH long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the GH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 59.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$920.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a GH long call?: The breakeven for the GH long call priced on this page is roughly $104.20 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GH market-implied 1-standard-deviation expected move is approximately 17.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on GH?: Long calls on GH express a bullish thesis with defined risk; traders use them ahead of GH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current GH implied volatility affect this long call?: GH ATM IV is at 59.60% with IV rank near 14.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.